CVS Health Co. (NYSE:CVS) Shares Bought by Sowell Financial Services LLC

Sowell Financial Services LLC lifted its holdings in shares of CVS Health Co. (NYSE:CVS) by 3.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,073 shares of the pharmacy operator’s stock after purchasing an additional 1,154 shares during the quarter. Sowell Financial Services LLC’s holdings in CVS Health were worth $2,453,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in CVS. Live Oak Investment Partners acquired a new stake in shares of CVS Health during the fourth quarter worth about $25,000. Atticus Wealth Management LLC increased its stake in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 219 shares during the period. Cornerstone Planning Group LLC increased its stake in shares of CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 243 shares during the period. PCA Investment Advisory Services Inc. purchased a new stake in shares of CVS Health during the second quarter worth approximately $37,000. Finally, ZRC Wealth Management LLC increased its stake in shares of CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after buying an additional 400 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.25% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of a number of recent research reports. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Royal Bank of Canada dropped their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research note on Thursday, February 8th. TD Cowen dropped their price target on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a research note on Monday, December 11th. SVB Leerink started coverage on shares of CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 price target on the stock. Finally, HSBC started coverage on shares of CVS Health in a research note on Friday, December 22nd. They issued a “buy” rating and a $94.00 price target on the stock. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Price Performance

Shares of NYSE CVS opened at $74.58 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a fifty day moving average price of $76.08 and a 200 day moving average price of $73.75. CVS Health Co. has a 1-year low of $64.41 and a 1-year high of $83.25. The company has a market cap of $93.86 billion, a PE ratio of 11.55, a P/E/G ratio of 0.98 and a beta of 0.52.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter last year, the company earned $1.99 earnings per share. CVS Health’s quarterly revenue was up 11.9% compared to the same quarter last year. Sell-side analysts forecast that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.57%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.